Search

Author/Creator Lara, Primo N.

1. A phase 2 clinical trial of everolimus plus bicalutamide for castration‐resistant prostate cancer. Issue 12 (28th March 2016)

Authors:
Chow, Helen; Ghosh, Paramita M.; deVere White, Ralph; Evans, Christopher P.; Dall'Era, Marc A.; Yap, Stanley A.; Li, Yueju; Beckett, Laurel A.; Lara, Primo N.; Pan, Chong‐Xian
Journal:
Cancer
Issue:
Volume 122:Issue 12(2016)
Page Start:
1897
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. A phase II study of vascular endothelial growth factor trap (Aflibercept, NSC 724770) in patients with myelodysplastic syndrome: a California Cancer Consortium Study. (21st September 2016)

Authors:
Kirschbaum, Mark H.; Frankel, Paul; Synold, Timothy W.; Zain, Jasmine; Claxton, David; Tuscano, Joseph; Newman, Edward M.; Gandara, David R.; Lara, Primo N.
Journal:
British journal of haematology
Issue:
Volume 180:Number 3(2018)
Page Start:
445
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Bevacizumab alone or in combination with TRC105 for patients with refractory metastatic renal cell cancer. Issue 23 (22nd August 2017)

Authors:
Dorff, Tanya B.; Longmate, Jeff A.; Pal, Sumanta K.; Stadler, Walter M.; Fishman, Mayer N.; Vaishampayan, Ulka N.; Rao, Amol; Pinksi, Jacek K.; Hu, James S.; Quinn, David I.; Lara, Primo N.
Journal:
Cancer
Issue:
Volume 123:Issue 23(2017)
Page Start:
4566
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Brief Reports - SWOG S0709: Randomized Phase II Trial of Erlotinib versus Erlotinib Plus Carboplatin/Paclitaxel in Patients with Advanced Non–Small Cell Lung Cancer and Impaired Performance Status as Selected by a Serum Proteomics Assay. Issue 3 (March 2016)

Authors:
Lara, Primo N.; Moon, James; Hesketh, Paul J.; Redman, Mary W.; Williamson, Stephen K.; Akerley, Wallace L.; Hirsch, Fred R.; Mack, Philip C.; Gandara, David R.
Journal:
Journal of thoracic oncology
Issue:
Volume 11:Issue 3(2016)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. EphrinB2 Inhibition and Pembrolizumab in Metastatic Urothelial Carcinoma. Issue 3 (19th August 2022)

Authors:
Sadeghi, Sarmad; Quinn, David; Dorff, Tanya; Pal, Sumanta; Groshen, Susan; Tsao-Wei, Denice; Parikh, Rahul; Devitt, Michael; Parikh, Mamta; Jackovich, Alexandra; Ruel, Nora; Vogelzang, Nicholas; Burgess, Earle; Siddiqi, Imran; Gill, Inderbir S.; Lara, Primo N.; Dreicer, Robert; Gill, Parkash S.
Journal:
Journal of clinical oncology
Issue:
Volume 41:Issue 3(2023)
Page Start:
640
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

9. Impact of an Interactive On-line Tool on Therapeutic Decision-Making for Patients with Advanced Non–Small-Cell Lung Cancer. Issue 10 (October 2015)

Authors:
Chow, Helen; Edelman, Martin J.; Giaccone, Giuiseppe; Ramalingam, Suresh S.; Quill, Timothy A.; Bowser, Andrew D.; Mortimer, Jim; Guerra, Wilma; Beckett, Laurel A.; West, Howard L; Lara, Primo N.; Gandara, David R.
Journal:
Journal of thoracic oncology
Issue:
Volume 10:Issue 10(2015)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

10. Impact of an Interactive On-line Tool on Therapeutic Decision-Making for Patients with Advanced Non–Small-Cell Lung Cancer. Issue 10 (October 2015)

Authors:
Chow, Helen; Edelman, Martin J.; Giaccone, Giuiseppe; Ramalingam, Suresh S.; Quill, Timothy A.; Bowser, Andrew D.; Mortimer, Jim; Guerra, Wilma; Beckett, Laurel A.; West, Howard L; Lara, Primo N.; Gandara, David R.
Journal:
Journal of thoracic oncology
Issue:
Volume 10:Issue 10(2015)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗